Research Collab
10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer
10x Genomics
PR-06-26-02Jun 17, 2026
Psych Biomarkers
Beyond Symptoms: The Search for Objective Biomarkers in Psychiatric Disorders
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-13May 12, 2026
Diagnostics
The Next Diagnostic Revolution: Faster, Smarter, More Personalized Care
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-25-NI-04Oct 9, 2025
Autoimmune Diseases
Pain, Misdiagnosis, and Autoimmune Disease: Untangling Complexity and Bias
Chia Chia Sun; David Alvaro, Ph.D.
Fab Biopharma
PAO-08-25-CL-03Aug 6, 2025
Digital Pathology
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
Nathan Buchbinder
Proscia
PAO-01-24-CL-2Feb 29, 2024
Artificial Intelligence
Artificial Intelligence in Pharma, As Told by Artificial Intelligence
Pharma's Almanac
PAO-01-23-CL-02Jan 13, 2023
Alzheimer's Diagnostic Test
FDA Permits Marketing for New Test to Improve Diagnosis of Alzheimer's Disease
U.S. Food & Drug Administration
PR-M05-22-02May 4, 2022
COVID-19 Breathalyzer Diagnostic
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
U.S. Food & Drug Administration
PR-M04-22-09Apr 14, 2022
COVID-19 Testing
FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing
U.S. Food & Drug Administration
PR-M07-20-NI-29Jul 21, 2020
COVID-19 Antibody Testing
Roche's Highly Accurate Antibody Test for COVID-19 Goes Live at More than 20 Initial Lab Sites in the U.S.
Roche
PR-M05-20-NI-035-1541May 22, 2020
FDA Statement
FDA Statement on Oral Fluid Test for COVID-19
U.S. Food & Drug Administration
PR-M04-20-NI-027Apr 20, 2020
RNA Biomarkers
RNA Biomarkers for Early Lung Cancer Diagnosis
Ron Andrews
OncoCyte
PAP-Q1-20-CL-014Mar 19, 2020
Research
Lilly, Evidation Health and Apple Study Shows Personal Digital Devices May Help in the Identification of Dementia
Eli Lilly and Company
PR-M08-19-NI-033Aug 13, 2019
Companion Diagnostics
Roche to Develop Companion Diagnostic Test to Help Identify Patients Eligible for Anti-PD-1 Therapy Based on Biomarker Expression, Not Location, of Solid Tumors
Roche
PR-M12-18-NI-050Dec 14, 2018
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's New Effort for Developing and Class Labeling of In Vitro Companion Diagnostics for Classes of Oncology Therapeutic Products
U.S. Food & Drug Administration
PR-M12-18-NI-034Dec 11, 2018
Collaboration
QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics
Qiagen
PR-M08-18-NI-034Aug 9, 2018